None administered in this study

BIOLOGICAL2 trials

Sponsors

Sanofi Pasteur, a Sanofi Company

Conditions

MeningitisMeningococcal Disease

Unknown Phase

Descriptive, Post-marketing, Surveillance Safety Study of Menactra Vaccine

CompletedNCT00254995

Sanofi Pasteur, a Sanofi CompanyMeningitis, Meningococcal Disease

Start: 2005-07-31End: 2013-05-31Updated: 2016-04-19

36-Month Post-marketing Surveillance and Analysis of Menactra Vaccine in 2-10 Year Olds

CompletedNCT00728260

Sanofi Pasteur, a Sanofi CompanyMeningitis, Meningococcal Disease

Start: 2005-07-31End: 2013-05-31Updated: 2015-02-12

Related Papers

Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D) in infants and children

Vaccine2018-03-1813 citations

Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine

Vaccine2017-09-2114 citations